Vestibular therapy for improving balance in Alzheimer's patients
Official title: Vestibular Therapy in Alzheimer's Disease
Run by Johns Hopkins University · NCT03799991 · Data updated 2026-11-12
This study is testing if vestibular therapy can help improve balance and reduce falls in people with Alzheimer's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | August 22, 2022 |
| Main results expected | August 26, 2027 |
| Study ends | August 26, 2027 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT03799991 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 60 and older with a diagnosis of mild to moderate Alzheimer's disease and evidence of vestibular loss.
✕Probably not a fit
Patients with severe cognitive impairment who cannot provide informed consent or participate in the therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of vestibular therapy in reducing falls among patients with Alzheimer's disease, who often experience balance and mobility issues. The study will involve a randomized controlled design, comparing vestibular physical therapy to an active control group. Participants will undergo vestibular physiologic testing, balance and gait assessments, and neurocognitive testing over an 8-week period. The goal is to determine if vestibular therapy can enhance balance stability in this population, which has not been previously studied.
Why it matters
Potential benefit: If successful, this therapy could significantly reduce the risk of falls in Alzheimer's patients, improving their safety and quality of life.
How similar studies have gone: This approach is novel, as vestibular therapy has not been previously tested in Alzheimer's patients, although it has shown effectiveness in improving balance in healthy older adults.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of AD based on the National Institute on Aging-Alzheimer Association 2011 criteria that is mild-moderate (CDR=0.5-2). * Age ≥ 60 years. * Vestibular loss defined as bilaterally impaired vestibular responses (semicircular canal or otolith responses). * Able to participate in study procedures including vestibular physiologic testing, balance and gait assessment, neurocognitive testing, and VT or active control. * Able to give informed consent, as further detailed in the Human Subjects section. The investigators anticipate that individuals who are too impaired to provide informed consent would also not be able to effectively participate in VT or active control. * Presence of a caregiver, defined as an individual who spends at least 10 hours per week with the patient. The caregiver must be able to participate in study procedures, specifically the text-messaging system. Both the VT and active control involve 8 weeks of once weekly visits and daily home exercises, and the investigators believe a caregiver would increase the likelihood of successful completion of either therapy. Exclusion Criteria: * Diagnosis of severe AD (CDR≥3). * Diagnosis of mild cognitive impairment or diagnosis of non-AD dementia, for example Parkinson's disease dementia, Dementia with Lewy Bodies, vascular dementia, fronto-temporal dementia, and primary progressive aphasia. * Deemed unable to participate in study procedures and VT or active control, (e.g. patients with significant medical comorbidities, excessive agitation, or use of mobility aids such as a cane or walker.) * Use of daily vestibular suppressant medications, specifically anti-histamines and benzodiazepines, as this can alter the response to VT. * Lack of availability to participate in 8 weeks of VT or active control.
Where it's running
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Yuri Agrawal, MD — Johns Hopkins University
- Study coordinator: Yuri Agrawal, MD
- Email: yagrawa1@jhmi.edu
- Phone: 4105023107
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.